|
| 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one Basic information |
Product Name: | 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one | Synonyms: | 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one;Entecavir (1S,3S,4S) Diastereomer;Entecavir impurity C;Entecavir Impurity G;Entecavir Impurity 7(Entecavir EP Impurity B);Entecavir impurity 5/(1S,3S,4S)-Entecavir/2-Amino-1,9-dihydro-9-[(1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;Entecavir EP Impurity B;2-amino-9-[(1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1~{H}-purin-6-one | CAS: | 1367369-77-4 | MF: | C12H15N5O3 | MW: | 277.28 | EINECS: | | Product Categories: | | Mol File: | 1367369-77-4.mol | |
| 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one Chemical Properties |
Boiling point | 661.4±65.0 °C(Predicted) | density | 1.81±0.1 g/cm3(Predicted) | pka | 14.22±0.60(Predicted) |
| 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one Usage And Synthesis |
Uses | An epimeric impurity of the antiviral drug Entecavir (E558900). |
| 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one Preparation Products And Raw materials |
|